Immunotherapies | Australian Biotech Company News

Home Tags Immunotherapies

Biotechnology

Engineering the Immune Response for Therapeutic Success

BioChannel - June 26, 2020

Biotechnology

Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation

BioChannel - June 1, 2020

Biotechnology

Brain Cancer CAR T Cell Therapy Guided by Scorpion Toxin Starts...

BioChannel - March 6, 2020

Biotechnology

GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration

BioChannel - February 20, 2020

Biotechnology

Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice

BioChannel - February 13, 2020

Biotechnology

OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer

BioChannel - January 24, 2020

Biotechnology

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

BioChannel - January 23, 2020

Biotechnology

Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline

BioChannel - December 27, 2019

Biotechnology

Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...

BioChannel - December 9, 2019

Biotechnology

Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...

BioChannel - October 4, 2019

12 Page 1 of 2

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News